These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

623 related items for PubMed ID: 17163256

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.
    Kragballe K, Noerrelund KL, Lui H, Ortonne JP, Wozel G, Uurasmaa T, Fleming C, Estebaranz JL, Hanssen LI, Persson LM.
    Br J Dermatol; 2004 Jun; 150(6):1167-73. PubMed ID: 15214905
    [Abstract] [Full Text] [Related]

  • 3. Use of calcipotriene cream (Dovonex cream) following acute treatment of psoriasis vulgaris with the calcipotriene/betamethasone dipropionate two-compound product (Taclonex): a randomized, parallel-group clinical trial.
    White S, Vender R, Thaçi D, Haverkamp C, Naeyaert JM, Foster R, Martinez Escribano JA, Cambazard F, Bibby A.
    Am J Clin Dermatol; 2006 Jun; 7(3):177-84. PubMed ID: 16734505
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy of treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol for the treatment of psoriasis vulgaris: a randomised, double-blind trial.
    Ortonne JP, Kaufmann R, Lecha M, Goodfield M.
    Dermatology; 2004 Jun; 209(4):308-13. PubMed ID: 15539894
    [Abstract] [Full Text] [Related]

  • 6. Efficacy, safety, and cost-effectiveness of all-trans retinoic acid/Clobetasol Propionate Compound Ointment in the treatment of mild to moderate psoriasis vulgaris: A randomized, single-blind, multicenter clinical trial.
    Xia L, Li R, Wang Y, Lin Z, Zheng J, Li X, Lu Q, Zhang J, Jin H, Fu L, Zhang X, Liu Y, Yang S, Xiao F, Gao XH.
    Dermatol Ther; 2018 Sep; 31(5):e12632. PubMed ID: 30253049
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Calcipotriol/betamethasone dipropionate: a review of its use in the treatment of psoriasis vulgaris of the trunk, limbs and scalp.
    McCormack PL.
    Drugs; 2011 Apr 16; 71(6):709-30. PubMed ID: 21504248
    [Abstract] [Full Text] [Related]

  • 9. Consistency of data in six phase III clinical studies of a two-compound product containing calcipotriol and betamethasone dipropionate ointment for the treatment of psoriasis.
    Kragballe K, van de Kerkhof PC.
    J Eur Acad Dermatol Venereol; 2006 Jan 16; 20(1):39-44. PubMed ID: 16405606
    [Abstract] [Full Text] [Related]

  • 10. The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet/ Dovobet) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trial.
    van de Kerkhof PC.
    Br J Dermatol; 2004 Sep 16; 151(3):663-8. PubMed ID: 15377355
    [Abstract] [Full Text] [Related]

  • 11. Efficacy results of a 52-week, randomised, double-blind, safety study of a calcipotriol/betamethasone dipropionate two-compound product (Daivobet/Dovobet/Taclonex) in the treatment of psoriasis vulgaris.
    Kragballe K, Austad J, Barnes L, Bibby A, de la Brassinne M, Cambazard F, Fleming C, Heikkilä H, Williams Z, Peyri Rey J, Svensson A, Toole J, Wozel G.
    Dermatology; 2006 Sep 16; 213(4):319-26. PubMed ID: 17135738
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Optimal maintenance treatment with calcipotriol/betamethasone dipropionate gel in Korean patients with psoriasis vulgaris: a multicentre randomized, controlled clinical trial.
    Lee JH, Park CJ, Kim TY, Choe YB, Kim NI, Song HJ, Youn JI, Youn SW, Choi JH, Kim KJ.
    J Eur Acad Dermatol Venereol; 2017 Mar 16; 31(3):483-489. PubMed ID: 27723134
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Calcipotriol/betamethasone dipropionate: a review of its use in the treatment of psoriasis vulgaris.
    Fenton C, Plosker GL.
    Am J Clin Dermatol; 2004 Mar 16; 5(6):463-78. PubMed ID: 15663344
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Topical calcipotriol/betamethasone dipropionate for psoriasis vulgaris: A systematic review.
    Yan R, Jiang S, Wu Y, Gao XH, Chen HD.
    Indian J Dermatol Venereol Leprol; 2016 Mar 16; 82(2):135-44. PubMed ID: 26924402
    [Abstract] [Full Text] [Related]

  • 20. Quality of life in patients with scalp psoriasis treated with calcipotriol/betamethasone dipropionate scalp formulation: a randomized controlled trial.
    Ortonne JP, Ganslandt C, Tan J, Nordin P, Kragballe K, Segaert S.
    J Eur Acad Dermatol Venereol; 2009 Aug 16; 23(8):919-26. PubMed ID: 19453810
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.